Seeger Weiss Represents Arlington County, Virginia in Insulin Pricing Lawsuit

Seeger Weiss attorneys Chris Seeger, David Buchanan and Steven Daroci filed a lawsuit on behalf of Arlington County, Virginia against insulin manufacturers Eli Lilly, Novo Nordisk, and Sanofi, and pharmacy benefit managers (PBMs) CVS Caremark, Express Scripts and OptumRx, for their alleged role in a scheme to aggressively inflate the price of insulin and other […]

November 14, 2023

Seeger Weiss attorneys Chris Seeger, David Buchanan and Steven Daroci filed a lawsuit on behalf of Arlington County, Virginia against insulin manufacturers Eli Lilly, Novo Nordisk, and Sanofi, and pharmacy benefit managers (PBMs) CVS Caremark, Express Scripts and OptumRx, for their alleged role in a scheme to aggressively inflate the price of insulin and other diabetes medications.

Over the past 20 years, the cost of insulin has risen several hundred percent, far outpacing the increase in the cost of production. This price inflation has not only placed a heavy financial burden on individuals who require insulin to manage their diabetes but also on government entities like Arlington County that bear the brunt of these inflated prices. The lawsuit seeks to recover damages for the increased costs borne by Arlington County due to the alleged pricing scheme and to prevent these companies from continuing their alleged unlawful, deceptive, and anticompetitive practices.

This case reflects Seeger Weiss’ ongoing commitment to representing clients in important public health litigation. The firm currently represents several government entities, including Albany County, New York; Lake County, Illinois; Monmouth County, New Jersey; the City of Cleveland, Ohio; and others that have filed similar lawsuits alleging that insulin manufacturers and PBMs are complicit in overcharging for these life-saving diabetes medications. Additionally, Seeger Weiss and its co-counsel successfully argued for the creation of a multidistrict litigation for these insulin pricing lawsuits in the District of New Jersey. The Judicial Panel on Multidistrict Litigation created the In re: Insulin Pricing Litigation MDL in August of this year.

One of the nation’s preeminent plaintiffs’ law firms, Seeger Weiss is best known for multidistrict mass torts and class actions in both state and federal court—and especially for taking those cases to trial. With the resources and dedication to take on the world’s largest corporations, the firm has an impressive track record of victories against companies like Merck, Monsanto, and 3M—and a reputation for sticking with a case from beginning to end. From offices in New York, New Jersey, and Pennsylvania, the firm has represented over 10,000 individuals, companies, and governments across the United States who have been injured or defrauded on a massive scale. Since its founding in 1999, it has led many of the most complex and high-profile cases in the country: the National Prescription Opiate Litigation, which the Washington Post called “the largest federal court case in U.S. history”; the ongoing “Dieselgate” scandal; the sprawling multistate litigation on behalf of survivors of child sexual abuse; and the history-making National Football League Players’ Concussion Injury Litigation.

Related News

July 28, 2026
Seeger Weiss Named Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards

Seeger Weiss has been named as Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards. This honor is reflects to the Seeger Weiss team’s efforts throughout the entire Pharmaceutical Litigation practice area, but specifically the firm’s work on the GLP-1 RA and Depo-Provera litigations. Partner Parvin Aminolroaya […]

Read More
July 28, 2026
Plaintiffs Reach Uncapped Global Settlement With J&J, Company to Pay Minimum of $5.8 Billion to Resolve Talc Litigation After More Than a Decade

The Plaintiffs’ Negotiation Committee in multi-district litigation 2738 (District of New Jersey), with the support and endorsement of the Plaintiffs’ Executive Committee and the Plaintiffs’ Steering Committee, announces today that it has reached a historic uncapped global settlement with J&J, Company to pay a minimum $5.8 billion settlement to resolve all current and pending talcum […]

Read More
June 29, 2026
Seeger Weiss Earns Tier 1 Ranking in the 2026 Legal 500 USA Guide

Seeger Weiss is proud to announce that the firm has been selected for a Tier 1 ranking in the 2026 Legal 500 USA Guide in the Product Liability, Mass Tort and Class Action: Plaintiff category. Founding Partner Christopher Seeger was selected for inclusion in the category’s Hall of Fame in recognition of his continued leadership […]

Read More